Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2014

Sep 3, 2014

35086_dirs_2014-09-03_b287b8cc-bb7a-405e-bb94-f21134f884c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2014-09-02

Reporting Person: Levine Mark S. (Vice President,General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-02 Employee Stock Option (Right to Buy) $7.10 A 93541 Acquired 2024-09-02 Common Stock (93541) Direct

Footnotes

F1: 25% of the shares subject to the option will become exercisable on August 14, 2015 and the balance of the shares will become exercisable in a series of twelve equal quarterly installments upon the reporting person's completion of each quarter of service over the three year period thereafter.